{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:18:02Z","timestamp":1791919082987,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903880"],"award-info":[{"award-number":["81903880"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.brainres.2023.148267","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T20:56:09Z","timestamp":1675112169000},"page":"148267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Icariin ameliorates behavioral deficits and neuropathology in a mouse model of multiple sclerosis"],"prefix":"10.1016","volume":"1804","author":[{"given":"Dan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceng-ceng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-ping","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui-cui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0116-4387","authenticated-orcid":false,"given":"Chao-ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2023.148267_b0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.trsl.2022.08.006","article-title":"NLRP3 inflammasome in neurodegenerative disease","volume":"252","author":"Anderson","year":"2023","journal-title":"Transl. Res."},{"key":"10.1016\/j.brainres.2023.148267_b0010","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","article-title":"Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues","volume":"19","author":"Benedict","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2023.148267_b0015","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awac233","article-title":"Contribution of B cells to cortical damage in multiple sclerosis","author":"Bhargava","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2023.148267_b0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrn3900","article-title":"Exploring the origins of grey matter damage in multiple sclerosis","volume":"16","author":"Calabrese","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2023.148267_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173523","article-title":"Icariin ameliorates the progression of experimental autoimmune encephalomyelitis by down-regulating the major inflammatory signal pathways in a mouse relapse-remission model of multiple sclerosis","volume":"885","author":"Cong","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2023.148267_b0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.brainresbull.2021.07.010","article-title":"Icariin ameliorates the cuprizone-induced acute brain demyelination and modulates the number of oligodendrocytes, microglia and astrocytes in the brain of C57BL\/6J mice","volume":"175","author":"Cong","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainres.2023.148267_b0035","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41582-020-0355-1","article-title":"Treatment and management of cognitive dysfunction in patients with multiple sclerosis","volume":"16","author":"DeLuca","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.brainres.2023.148267_b0040","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/brain\/awz212","article-title":"Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis","volume":"142","author":"Elliott","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2023.148267_b0045","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41573-019-0035-2","article-title":"Progressive multiple sclerosis: from pathophysiology to therapeutic strategies","volume":"18","author":"Faissner","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.brainres.2023.148267_b0050","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/brain\/awaa117","article-title":"Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions","volume":"143","author":"Fransen","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2023.148267_b0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00011-018-1185-0","article-title":"A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future","volume":"68","author":"Gholamzad","year":"2019","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.brainres.2023.148267_b0060","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4049\/jimmunol.0904145","article-title":"NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses","volume":"185","author":"Gris","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.brainres.2023.148267_b0065","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102642118","article-title":"IFP35 family proteins promote neuroinflammation and multiple sclerosis","volume":"118","author":"Jing","year":"2021","journal-title":"PNAS"},{"key":"10.1016\/j.brainres.2023.148267_b0070","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/brain\/awaa135","article-title":"The NLRP3 inflammasome in progressive multiple sclerosis","volume":"143","author":"Kadowaki","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2023.148267_b0075","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s41593-022-01097-3","article-title":"Identification of early neurodegenerative pathways in progressive multiple sclerosis","volume":"25","author":"Kaufmann","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2023.148267_b0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10787-017-0401-9","article-title":"Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain","volume":"26","author":"Khan","year":"2018","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.brainres.2023.148267_b0085","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41582-021-00556-y","article-title":"Apparent changes in the epidemiology and severity of multiple sclerosis","volume":"17","author":"Koch-Henriksen","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.brainres.2023.148267_b0090","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bbi.2020.11.004","article-title":"Therapeutic role of inflammasome inhibitors in neurodegenerative disorders","volume":"91","author":"Lahooti","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainres.2023.148267_b0095","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/glia.22597","article-title":"Mechanisms of white matter damage in multiple sclerosis","volume":"62","author":"Lassmann","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.brainres.2023.148267_b0100","doi-asserted-by":"crossref","unstructured":"Lie, I.A., Weeda, M.M., Mattiesing, R.M., Mol, M.A.E., Pouwels, P.J.W., Barkhof, F., Torkildsen, \u00d8., B\u00f8, L., Myhr, K.M., Vrenken, H., 2022. Relationship Between White Matter Lesions and Gray Matter Atrophy in Multiple Sclerosis: A Systematic Review. Neurology. 98, e1562-e1573.","DOI":"10.1212\/WNL.0000000000200006"},{"key":"10.1016\/j.brainres.2023.148267_b0105","doi-asserted-by":"crossref","first-page":"9974625","DOI":"10.1155\/2021\/9974625","article-title":"Icariin promotes survival, proliferation, and differentiation of neural stem cells in vitro and in a rat model of Alzheimer's disease","volume":"2021","author":"Ma","year":"2021","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.brainres.2023.148267_b0110","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41582-022-00675-0","article-title":"Emerging therapies to target CNS pathophysiology in multiple sclerosis","volume":"18","author":"Oh","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.brainres.2023.148267_b0115","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/brain\/awab132","article-title":"Deep grey matter injury in multiple sclerosis: a NAIMS consensus statement","volume":"144","author":"Ontaneda","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2023.148267_b0120","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/540S1a","article-title":"Multiple sclerosis","volume":"540","author":"Owens","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2023.148267_b0125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-052920-040318","article-title":"The immune response in multiple sclerosis","volume":"17","author":"Rodr\u00edguez Mur\u00faa","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.brainres.2023.148267_b0130","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00281-019-00765-0","article-title":"Resolution of inflammation during multiple sclerosis","volume":"41","author":"Ruiz","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.brainres.2023.148267_b0135","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.intimp.2014.12.015","article-title":"A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis","volume":"24","author":"Shen","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.brainres.2023.148267_b0140","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajem.2022.10.041","article-title":"Resource equation method for sample size calculation in animal studies","volume":"63","author":"Sohn","year":"2023","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.brainres.2023.148267_b0145","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.13050","article-title":"Altered muscle oxidative phenotype impairs exercise tolerance but does not improve after exercise training in multiple sclerosis","author":"Spaas","year":"2022","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.brainres.2023.148267_b0150","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1474-4422(21)00170-8","article-title":"Multiple sclerosis under the spotlight","volume":"20","author":"The Lancet Neurology","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2023.148267_b0155","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/ene.14685","article-title":"Assessing the experience of the quality of care of patients living with multiple sclerosis and their caregivers: the MusiCare questionnaire","volume":"28","author":"Veillard","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.brainres.2023.148267_b0160","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201810248","article-title":"Inflammasomes in neuroinflammatory and neurodegenerative diseases","volume":"11","author":"Voet","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.brainres.2023.148267_b0165","doi-asserted-by":"crossref","unstructured":"Walton, C., King, R., Rechtman, L., Kaye, W., Leray, E., Marrie, R.A., Robertson, N., La Rocca, N., Uitdehaag, B., van der Mei, I., Wallin, M., Helme, A., Angood Napier, C., Rijke, N., Baneke, P., 2020. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 26, 1816-1821.","DOI":"10.1177\/1352458520970841"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899323000379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899323000379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:08:09Z","timestamp":1762103289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899323000379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":33,"alternative-id":["S0006899323000379"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2023.148267","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Icariin ameliorates behavioral deficits and neuropathology in a mouse model of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2023.148267","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"148267"}}